Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

IL-29/IFN-lambda 1 Mouse anti-Human, Clone: B-Z29, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

$366.50 - $699.00

Specifications

Antigen IL-29/IFN-lambda 1
Clone B-Z29
Concentration 1 mg/ml
Dilution ELISA
Applications ELISA
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
NB160237
SDP
View Documents
Novus Biologicals
NBP318107200UL
200 μg
Each for $366.50
Only null left
Add to Cart
 
NB160238
SDP
View Documents
Novus Biologicals
NBP318107500UL
500 μg
Each for $699.00
Only null left
Add to Cart
 
Description

Description

IL-29/IFN-lambda 1 Monoclonal antibody specifically detects IL-29/IFN-lambda 1 in Human samples. It is validated for ELISA
Specifications

Specifications

IL-29/IFN-lambda 1
1 mg/ml
ELISA
Unconjugated
Mouse
Biologically Active Proteins
PBS. Sterile-filtered through 0.22 um.
282618
IgG2a κ
Affinity purified
B-Z29
ELISA
Monoclonal
Purified
RUO
Human
cytokine Zcyto21, IFNL1, IFN-lambda-1, IL-29, interferon lambda-1, interferon, lambda 1, interleukin 29 (interferon, lambda 1), interleukin-29, ZCYTO21
Recombinant human IL-29/IFN-lambda 1. Hybridoma: Myeloma X63/AG.8653 x Balb/c node cells
Primary
Store at 4C short term. Aliquot and store at -70C long term. Avoid freeze-thaw cycles.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.